SHANGHAI, China, Oct. 10, 2026 (GLOBE NEWSWIRE) — FREELANDER has outlined the global validation programme for FREELANDER 8 ahead of the first test drive of its international variant at the 2026 Chery International User Summit in Wuhu later this month. The programme involved more than 1,000 test vehicles across more than 50 road types worldwide. Key engineering results were presented at the FREELANDER Global Brand Launch, held at Emirates Palace Mandarin Oriental in Abu Dhabi on 29 September 2026. Two FREELANDER 8 vehicles on a gravel track in rocky mountain terrain A Global Validation Programme More than 200 vehicles were dedicated to all-terrain durability testing, covering a combined 2.15 million kilometres. The wider programme covered deserts, gravel roads, rocky terrain, steep inclines, water crossings and paved roads. It also...

WUHU, China, Oct. 10, 2026 (GLOBE NEWSWIRE) — The 2026 Chery International User Summit will take place from October 18 to 24, alongside an exclusive media test drive event featuring Chery Group’s LUXEED models. Leading media representatives and key opinion leaders (KOLs) from the United Arab Emirates, Thailand, and Indonesia will get behind the wheel of LUXEED’s latest global offerings, embarking on an immersive driving experience that spans long-distance highway driving, scenic mountain passes, and a professional proving ground.Bringing together 15 influential media professionals and KOLs from across the region, the event will evaluate LUXEED’s capabilities from diverse perspectives, with a focus on the priorities of global markets. Participants will tackle a 185-kilometer route combining high-speed expressways and winding...

WUHU, China, Oct. 10, 2026 (GLOBE NEWSWIRE) — As the 2026 Chery International User Summit, operated by Chery Group, taking place from October 18 to 24 in Wuhu, China, draws near, LUXEED is set to launch an extensive global media test drive. Bringing together media representatives and key opinion leaders (KOLs) from around the world, the event will offer an immersive journey from urban streets to cloud-wrapped mountain peaks, focusing on real-world intelligent driving capabilities and dynamic vehicle performance.This media test drive will feature a comprehensive blend of real-road driving and professional proving ground evaluations. Departing from Chery International Headquarters, the fleet will navigate urban thoroughfares, expressways and winding mountain highways before arriving at the Guangde Proving Ground. Spanning approximately...

New research spotlights hypoglycemia-related burdens in adults with type 1 diabetes using automated insulin delivery systems HIGH POINT, N.C., Oct. 10, 2026 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company advancing cadisegliatin, a novel oral investigational therapy for type 1 diabetes (T1D), today announced that Chief Medical Officer Thomas Strack, M.D., Ph.D., presented research spotlighting hypoglycemia-related burdens among adults with T1D using automated insulin delivery (AID) systems at the inaugural Breakthrough T1D Clinical & Research Congress (CRC 2026) in Philadelphia, PA. Cadisegliatin is a potential first-in-class, liver-selective glucokinase activator (GKA) being evaluated as an oral adjunctive therapy to insulin for the treatment of T1D.        “A Cumulative Population...

NEW YORK, Oct. 10, 2026 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders, today announced the presentation of four posters at the 39th European College of Neuropsychopharmacology (ECNP) Congress, taking place in Munich, Germany from October 10-13, 2026. The posters highlight new preclinical data describing LB-102’s differentiated mechanism of action, the pivotal program of LB-102 in schizophrenia (NOVA-2 and NOVA-3), the ongoing late-stage development of LB-102 in bipolar depression (ILLUMINATE-1), and a previously reported analysis of LB-102’s impact on cognitive performance from the Phase 2 NOVA-1 trial in schizophrenia. “Our...

RISE Dispensaries will serve medical patients in one of Southwest Florida’s fastest-growing, waterfront communities with the opening of RISE Dispensary Cape Coral, located at 928 NE Pine Island Road. RISE Dispensary Cape Coral opens Oct. 10 and will celebrate its grand opening event on Saturday, Oct. 31 at 9:00 a.m. ET. Continuing with RISE’s new store opening tradition, a portion of profits from RISE Dispensary Cape Coral’s grand opening will benefit local nonprofit The Grateful Veteran.CHICAGO and VANCOUVER, British Columbia, Oct. 10, 2026 (GLOBE NEWSWIRE) — RISE Dispensaries, an industry-leading cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), today announced the opening of RISE Dispensary Cape Coral, Florida, on October 10. Located at 928 NE Pine Island...

KUALA LUMPUR, Malaysia, Oct. 10, 2026 (GLOBE NEWSWIRE) — Sigenergy is making its third appearance at the International Greentech & Eco Products Exhibition & Conference Malaysia (IGEM), showcasing its latest intelligent energy solutions and strengthening strategic partnerships across the Malaysian market.A key highlight of the event is the keynote presentation, “Sigenergy: Innovating with AI, Powering the Future Together,” which explores how AI-driven innovation is shaping the next generation of smart energy systems and supporting the transition toward a more sustainable energy future. Sigenergy also marked an important milestone in its local ecosystem through MOU exchanges with strategic partners Milieu and YT Energy, a subsidiary of Yayasan Pahang, reinforcing collaboration to accelerate the adoption of advanced energy...

Furoscix ReadyFlow™Furoscix ReadyFlow™Furoscix ReadyFlow™Furoscix ReadyFlow™New analyses on Furoscix ReadyFlow PK/PD performance delivered via an autoinjector demonstrated comparable urine output to IV furosemide Consistent bioavailability, diuresis and natriuresis across injection sites support flexible administration in clinical practice Cross-study analysis demonstrates comparable diuretic and natriuretic responses between Furoscix ReadyFlow and Furoscix® (furosemide) On-body Infusor, supporting a seamless transition to ReadyFlow Data presentations build on the July 2026 FDA approval and U.S. launch of Furoscix ReadyFlow, the first and only autoinjector delivering IV-equivalent diuretic therapy for heart failure- and CKD-related edema (fluid overload)WESTLAKE VILLAGE, Calif., Oct. 09,...

Votes received to date have been overwhelmingly in support Meeting has been adjourned to October 29, 2026 to meet approval requirement Unitholders with questions or who require assistance voting should contact BEP’s proxy solicitation agent, Laurel Hill Advisory Group, by calling 1-877-452-7184 (toll-free within North America) or 1-416-304-0211 (outside of North America), texting “INFO” to either number, or by emailing assistance@laurelhill.com.BROOKFIELD, NEWS, Oct. 09, 2026 (GLOBE NEWSWIRE) — Brookfield Renewable Partners (“BEP”) (TSX: BEP.UN, NYSE: BEP) today announced a new date for the special meeting of unitholders of BEP (the “Unitholders’ Meeting” or the “Meeting”) in respect of the proposed corporate structure simplification (the “Simplification”). Votes received to date demonstrate overwhelming support for the Simplification,...

Investment supports attainable housing for working individuals and families and helps leverage innovative public-private-philanthropic housing programs. EVERETT, Wash., Oct. 09, 2026 (GLOBE NEWSWIRE) — Coastal Community Bank (the “Bank”, “Coastal”, “our”) announced its participation in Koz Development’s PNW Attainable Workforce Housing Fund, a community development investment focused on expanding high-quality, environmentally responsible housing for working individuals and families across the Pacific Northwest. Koz Development’s PNW Attainable Workforce Housing Fund (“Fund”) was established to provide equity financing for attainable and workforce housing in growing communities throughout Washington and Oregon. The Fund focuses on well-located housing near employment centers, educational institutions, transportation,...